Correlation Between Cboe UK and Tissue Regenix

Can any of the company-specific risk be diversified away by investing in both Cboe UK and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cboe UK and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cboe UK Consumer and Tissue Regenix Group, you can compare the effects of market volatilities on Cboe UK and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cboe UK with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cboe UK and Tissue Regenix.

Diversification Opportunities for Cboe UK and Tissue Regenix

0.69

Correlation Coefficient

Cboe UK  Tissue Regenix

Poor diversification

The 3 months correlation between Cboe and Tissue is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cboe UK Consumer and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and Cboe UK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cboe UK Consumer are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of Cboe UK i.e., Cboe UK and Tissue Regenix go up and down completely randomly.

Pair Corralation between Cboe UK and Tissue Regenix

Assuming the 90 days trading horizon Cboe UK Consumer is expected to generate 0.49 times more return on investment than Tissue Regenix. However, Cboe UK Consumer is 2.05 times less risky than Tissue Regenix. It trades about -0.14 of its potential returns per unit of risk. Tissue Regenix Group is currently generating about -0.36 per unit of risk. If you would invest  3,188,749  in Cboe UK Consumer on December 25, 2024 and sell it today you would lose (285,273) from holding Cboe UK Consumer or give up 8.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cboe UK Consumer  vs.  Tissue Regenix Group

Pair Trading with Cboe UK and Tissue Regenix

The main advantage of trading using opposite Cboe UK and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cboe UK position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.

The idea behind Cboe UK Consumer and Tissue Regenix Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.